First Immunotherapy Approved for Gastric Cancer – Medscape
MedscapeFirst Immunotherapy Approved for Gastric CancerMedscapeThe US Food and Drug Administration (FDA) today approved pembrolizumab (Keytruda, Merck) for treatment of gastric or gastroesophageal junction cancer. Pembrolizumab becomes the first immuno… Continue reading
